Long-Term Outcomes Among Two-Year Survivors of Autologous Hematopoietic Cell Transplant for Hodgkin and Diffuse Large B-Cell Lymphoma

BACKGROUND: Autologous hematopoietic cell transplant (autoHCT) is a standard therapy for relapsed Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL); however, long-term outcomes are not well described. METHODS: We analyzed survival, non-relapse mortality, late effects and subsequent ma...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer
Huvudupphovsmän: Myers, Regina, Hill, Brian T., Shaw, Bronwen E., Kim, Soyoung, Millard, Heather R., Battiwalla, Minoo, Majhail, Navneet, Buchbinder, David, Lazarus, Hillard M., Savani, Bipin N., Flowers, Mary E.D., D’Souza, Anita, Ehrdardt, Matt, Langston, Amelia, Yared, Jean, Hayashi, Robert J., Daly, Andrew, Olsson, Richard F., Inamoto, Yoshi, Malone, Adriana K., DeFilipp, Zachariah, Margossian, Steven, Warwick, Anne, Jaglowski, Samantha, Beitinjaneh, Amer, Fung, Henry, Kasow, Kimberly, Marks, David I., Reynolds, Jana, Stockerl-Goldstein, Keith, Wirk, Baldeep M., Wood, William, Hamadani, Mehdi, Satwani, Prakash
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871233/
https://ncbi.nlm.nih.gov/pubmed/29125192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31114
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk